Agile Therapeutics Inc (STU:0AL)
€ 9.83 0 (0%) Market Cap: 7.41 Mil Enterprise Value: 4.63 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Agile Therapeutics Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 20, 2021 / 07:45PM GMT
Release Date Price: €1765 (+3.46%)
Leland Gershell
Oppenheimer & Co. Inc. - Analyst

Thank you. Good afternoon, everyone, and welcome to our first day of Oppenheimer's Virtual Fall Healthcare Summit and MedTech Conference. We are delighted to have with us for this session Agile Therapeutics. Agile is launching its first product, which is a once-weekly contraceptive patch for women. We are delighted to have the CEO of the Company, Al Altomari, with us, and he will be walking through the story.

If you have any questions, please be sure to post those in the chat session -- chat function on Zoom, and I will do my best to ask them on your behalf. And with that, I will turn the podium over to Al.

Al Altomari
Agile Therapeutics, Inc. - Chairman, CEO & Director

Great. Thank you, Leland. Also, like to thank you and the OpCo organization for this chance. We love coming to these conferences to meet new investors and spread the word about what we're trying to do at Agile. And so, thanks for this chance to give an update to your listeners.

I think you're aware for everybody

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot